MARSHALL WACE, LLP

Position in PRQR — ProQR Therapeutics N.V.

CIK 1318757 LONDON, X0

Position in PRQR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$187,830

+$30,116 QoQ

Shares Held

115,945

+94.8% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. PRQR ranks #259 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,099,318	$363,731,344
2	VRTX	Vertex Pharmaceuticals Inc / Ma	317,058	$141,579,078
3	INCY	Incyte Corp	1,253,138	$117,945,347
4	RPRX	Royalty Pharma plc	2,120,692	$101,729,594
5	RCUS	Arcus Biosciences, Inc.	3,761,437	$81,247,039
6	PTGX	Protagonist Therapeutics, Inc	628,075	$66,199,104
7	ROIV	Roivant Sciences Ltd.	2,246,943	$62,240,320
8	COGT	Cogent Biosciences, Inc.	1,600,168	$61,590,466

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$187,830	115,945	+94.8%	Shares	Other	2026-05-15
2024-12-31	$157,714	59,515	+490.1%	Shares	Other	2025-02-13
2023-12-31	$19,968	10,085	-82.5%	Shares	Other	2024-02-14
2023-09-30	$75,032	57,717	-81.3%	Shares	Other	2023-11-14
2023-06-30	$501,323	309,459	-50.6%	Shares	Other	2023-08-14
2023-03-31	$1,335,352	626,926	+49.0%	Shares	Other	2023-05-15
2022-12-31	$1,556,275	420,615	+472.8%	Shares	Other	2023-02-14
2022-09-30	$54,631	73,430	-57.1%	Shares	Other	2022-11-14
2022-06-30	$133,171	171,172	-46.1%	Shares	Other	2022-08-15
2021-03-31	$2,100,030	317,705	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.